Demyelinating lesions are not clinically curable and are a disease that can have a serious impact on the patient’s life, damaging the nerve centers. Patients with demyelinating lesions gradually develop headaches, nausea, dizziness, poor concentration, urinary incontinence and sexual dysfunction. At the same time, there is weakness and numbness of the limbs, patients will not be able to walk, there will be visual impairment, and sometimes there will be a sudden loss of consciousness, the temper will become more irritable, and in severe cases, it will lead to paralysis and dementia. For patients with demyelinating lesions, hormonal symptomatic treatment can be used in the early stage, such as epinephrine, dexamethasone and prednisone, and surgery can be chosen for treatment if necessary.